Skip to content

The efficacy of one of the Iranian Traditional Remedy on spermogram in infertile men

The efficacy of one of the Iranian Traditional Remedy(lobub morakab) in spermogram parameter in Idiopathic Male Infertility in Imam Khomeyni hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015100624377N1
Enrollment
43
Registered
2015-11-06
Start date
2015-09-23
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Diseases of male genital organs,Male infertility,

Interventions

Remedy recommended 5 g, twice a day with milk for 3 months.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Men 20-45 years Infertility for at least one year Unexplained Oligo-astheno-teratozoospermia according to WHO criteria: Sperm concentrations below 20 million per milliliter; 5. Motile sperm less than 50%; 6. The normal morphology less than 30%

Exclusion criteria

Exclusion criteria: History of taking chemotherapy, Corticosteroid, Anticoagulation, Testosterone, Antiandrogen The incidence of severe cases of oligospermia (sperm concentration less than one million per milliliter) Infections, genital anatomical abnormalities, chromosomal abnormalities, history of surgery on the genital tract, exposure to toxins Alcohol or drug abuse Systemic diseases (cancer, thyroid disease, liver and gall bladder diseases, renal failure, etc.) The reluctance of patients to continue Make any side effects from medication

Design outcomes

Primary

MeasureTime frame
Semen volume. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Semen analysis.;Sperm count. Timepoint: At the begining of the trial, 3 months after end of the drug. Method of measurement: Sperm analysis.;Sperm motility. Timepoint: At the begining of the trial, 3months after end of the drug. Method of measurement: Semen analysis.;Normal morphology. Timepoint: At the begining of the trial, 3months after end of the dru. Method of measurement: Semen analysis.

Secondary

MeasureTime frame
Fertility. Timepoint: After treatment. Method of measurement: Partner pregnancy.;Side effects such as itching, etc. Timepoint: During the intervention. Method of measurement: Patient report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaye Mahroozade

School of Persian Medicine, Iran University of Medical Sciences

dr.mahroozade@gmail.com+98 21 5563 9667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026